Recommended Papers Shared by Cristiane Bergerot
Cristiane D Bergerot/X

Recommended Papers Shared by Cristiane Bergerot

Cristiane Bergerot, Former Postdoc Fellow and Research Consultant at City of Hope, shared several articles from JCO Oncology Advances on X:

1.“Phase Ib/II study: adding acalabrutinib to R-CHOP was feasible, well tolerated across age groups, and associated w encouraging long-term outcomes in newly diagnosed DLBCL, supporting ongoing RCT to define its role in frontline treatment.”

Title: Acalabrutinib in Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone as First-Line Therapy for Patients With Diffuse Large B-Cell Lymphoma

Authors: Andrew J. Davies, Louise Stanton, Joshua Caddy, Nicola Campbell, Graham P. Collins, Katy McLaughlin, Christopher Wignall, Geoff N. Saunders, Christopher P. Fox, Robert Waugh, Kirit M. Ardeshna, Thomas E. Cummin, Francesco Cucco, Zi Chen, Ming-Qing Du, Anna Schuh, Niamh Appleby, John A. Radford, David J. Lewis, Adam R. Coleman, Cathy Burton, Sharon Barrans, Gareth Griffiths, Peter W. M. Johnson

Read the Article.

Recommended Papers Shared by Cristiane Bergerot

2.“Routine prophylactic PEG placement may not reduce hospitalization during HNC treatment, supporting an individualized approach to feeding tube placement.”

Title: Unplanned Hospitalization and Percutaneous Endoscopic Gastrostomy Tube Use for Head and Neck Cancer

Authors: Sung Jun Ma, Daniel Alvarez, Krithik Tella, Jacob Wells, Alec Kotler, Darien Reed, Kevin Agner, Om Desai, Matthew Nguyen, Andrew Koempel, Simeng Zhu, Priyanka Bhateja, Emile Gogineni, David Konieczkowski, Darrion Mitchell, Sachin Jhawar, John Grecula, Lauren Miller, James Rocco, Marcelo Bonomi, Dukagjin Blakaj

Read the Article.

Recommended Papers Shared by Cristiane Bergerot

3.“Risk-adapted local therapy achieved excellent local control and allowed selected patients to omit radiation after complete resection. The optimal role of maintenance therapy remains uncertain.”

Title: RMS13: A Phase II Trial Using Risk-Adapted Proton Beam Radiation and Surgery With Addition of Antiangiogenic Maintenance Chemotherapy in Intermediate-Risk Rhabdomyosarcoma

Authors: Jessica Gartrell, Tushar Patni, Yimei Li, Daniel J. Indelicato, Sara M. Federico, Andrew M. Davidoff, Sara Helmig, Elizabeth Stewart, Christopher L. Tinkle, John T. Lucas, Jr., Mary E. McCarville, Eric Sandler, Karen Albritton, Chia-ho Hua, Alberto S. Pappo, Matthew J. Krasin

Read the Article.

Recommended Papers Shared by Cristiane Bergerot